Congenital brucellosis: A case report.
Yahya Ali MohzariRenad Abdullah AlshuraimSyed Mohammed Basheeruddin AsdaqSaud O ALanaziNajwa AlghamdiAhmed A AlrashedAmal Khalil HassounheMeshal A AlzaaqiPublished in: The Journal of international medical research (2021)
Although rare, brucellosis is endemic in the Kingdom of Saudi Arabia (KSA). In the case presented here, a neonate was born at 29 weeks gestation with severe respiratory depression, pyrexia; hypotension and an elevated white blood cell count. Her mother was a 19-year-old pregnant woman who developed premature rupture of the membranes and went into labour early. Sepsis was suspected and so the neonate received dobutamine and empiric ampicillin/gentamicin. The mother reported visiting a farm during her pregnancy and so congenital brucellosis was considered a possibility. Blood cultures were positive for Gram-negative coccobacilli and serology confirmed the presence of Brucella abortus and B. meltiness. Antibiotic treatment was changed to rifampin/gentamicin/ciprofloxacin but on day 17 the baby deteriorated and gentamicin was discontinued and meropenem was added. The neonate gradually improved; meropenem was discontinued on day 24 and the baby was discharged from hospital on day 38.
Keyphrases
- gram negative
- saudi arabia
- multidrug resistant
- gestational age
- preterm birth
- pseudomonas aeruginosa
- preterm infants
- healthcare
- pregnant women
- acute kidney injury
- depressive symptoms
- intensive care unit
- single cell
- cell therapy
- pulmonary embolism
- low birth weight
- pregnancy outcomes
- early onset
- stem cells
- case report
- emergency department
- septic shock
- sleep quality
- adverse drug
- drug induced
- bone marrow